Knife-assisted full-thickness resection for rectal lesions in a multicenter setting

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This multicenter observational study collects data from patients who had knife-assisted full-thickness resection (kFTR) for rectal lesions. The researchers look at technical success, whether the lesion was removed in one piece with clean margins, and complication rates, including bleeding and post-procedure issues. Secondary outcomes include hospital stay, need for additional surgery, cancer recurrence, and death. Data are drawn from participating centers to describe real-world performance of kFTR for early rectal cancers.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patients aged 18 years and older
* Knife-assisted full-thickness resection (kFTR) performed for a rectal lesion at a participating center

Exclusion Criteria:

* Unavailable information regarding kFTR technical outcomes

Where it's running

• University Hospital Ghent
  Ghent, Belgium Recruiting

Study contacts

• Principal investigator: David Tate — University Hospital, Ghent
• Study coordinator: David Tate
• Email: studiestissue.resectie@uzgent.be
• Phone: 093321063

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Personalized 3D Bioprinted Colorectal Cancer Microenvironment Model

  This study tests patient-derived, 3D-bioprinted cancer models that include tumor, fibroblast, and immune cells to see if they can better predict how colorectal cancer will respond to treatment.

  Recruiting Peking Union Medical College Hospital · Ningbo, Zhejiang · NCT07919418

• Integrated genomic and clinical database for cancer biomarker discovery

  Researchers are building a combined genomic and clinical database at Samsung Medical Center to test biomarkers for cancer diagnosis, treatment choice, and predicting how well treatments work.

  Recruiting Samsung Medical Center · Seoul, Gang-Nam · NCT07911267

• Prehabilitation with Resistance, Aerobic, or Both Before Colorectal Surgery

  Four pre-surgery exercise options (resistance, aerobic, both, or none) will be tested to see which best reduces complications after colorectal cancer surgery.

  Recruiting Semmelweis University · Budapest · NCT07896174

• Liver transplantation for colorectal cancer with liver metastases

  This study follows adults with stage IV colorectal cancer whose disease is limited to the liver and who are getting a liver transplant as part of their cancer care to see how they fare over time.

  Recruiting Pontificia Universidad Catolica de Chile · Santiago, Santiago Metropolitan · NCT07884110

• LTZ-232: a first-in-human test in advanced colorectal and other solid tumors

  A first-in-human study tests LTZ-232, a new therapy for adults with unresectable or metastatic colorectal cancer and other solid tumors that have not responded to standard treatments.

  Recruiting Phase 1 LTZ Therapeutics, Inc. · Scottsdale, Arizona · NCT07878988

• SumMET: Targeted radioligand therapy for c-MET–positive solid tumors

  This first‑in‑human study tests the safety and potential effectiveness of a radioligand therapy called [225Ac]Ac-FL-261 in adults with advanced or metastatic solid tumors that overexpress c-MET.

  Recruiting at 2 sites Phase 1/2 Full-Life Technologies UK Limited · Minneapolis, Minnesota and 1 other locations · NCT07873450

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.